Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
TARLATAMAB-DLLE 10 MG IV SOLR [169431] (NDC 55513-069-01) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 17, 2026 , from http://ppman.hank.ai/transparency/procedure/55513-069-01/by-state?code_type=NDC
“TARLATAMAB-DLLE 10 MG IV SOLR [169431] (NDC 55513-069-01) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/55513-069-01/by-state?code_type=NDC. Accessed
November 17, 2026 .
“TARLATAMAB-DLLE 10 MG IV SOLR [169431] (NDC 55513-069-01) by State,” HANK Price Transparency ,
accessed November 17, 2026 ,
http://ppman.hank.ai/transparency/procedure/55513-069-01/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
55513-069-01 — Tarlatamab-dlle 10 Mg IV Solr [169431]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$29,100
National median
$29,100 – $29,100
IQR (p25 – p75)
1
hospitals filing
1
states
Walking in without insurance?
Cash / self-pay price
Cash median
$15,724
vs. negotiated
-46.0%
Hospitals reporting
6
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 55513-069-01 (NDC), with interquartile range
State Median p25 p75
MD $29,100 $29,100 $29,100